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Social cognition is a domain of cognitive function that includes the ability to understand andmanage social interactions. Emotional
intelligence (EI) has been identified as a component of social cognition and is defined as the ability to identify, use, understand,
and manage emotions. Neurocognitive impairments are known to be associated with poorer social function in people with
schizophrenia, but less is known about the relationships between EI, neurocognition, and social function. The current study
assessed EI using the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) in 20 people with schizophrenia and 20
controls. The schizophrenia group had significantly lower scores on all measures of EI and demonstrated poorer neurocognition
and social functioning than controls. The diﬀerence between schizophrenia and control groups was greatest for the Understanding
Emotions Branch of the MSCEIT. The neurocognition score and total EI score accounted for 18.3% of the variance in social
function in the control group and 9.1% of the variance in social function in the schizophrenia group. Our results suggest that a
total EI score is not a useful predictor of overall social function and it may be more clinically useful to develop an individual profile
of social cognitive abilities, including EI, to form a remediation program.
1. Introduction
Social cognition refers to aspects of cognition that are critical
for social functioning and interpersonal relationships, such
as accurate perception of the emotions of others, the ability
to recognize important social cues, theory of mind (TOM),
and the management of emotions in social situations [1].
Various components of social cognition have been found to
be impaired in people with schizophrenia [2, 3]. Impaired
social cognition may also be a risk factor for psychosis—
Kim et al. [4] reported that poor performance on social
cognition tasks was associated with higher rates of transition
to psychosis in young people who were at ultra-high risk of
psychosis.
Emotional intelligence (EI) is an important component
of social cognition [5, 6]. EI is defined as the ability to
process, understand, and manage emotions. EI is most com-
monly assessed using the Mayer-Salovey-Caruso Emotional
Intelligence Test, Version 2.0 (MSCEIT) [7, 8]. Mayer and
Salovey [6] identified four components (termed Branches)
of EI. The four Branches are Identifying Emotions (the
perception of emotion in the self and others); Facilitating
or Using Emotions (the capacity to use and generate
emotions, and to use emotions in cognitive tasks such as
problem-solving and creativity); Understanding Emotions
(the ability to comprehend complex information about
emotions, including changes or degrees of emotion); and
Managing Emotions (the ability to regulate emotions in
ourselves and others, and use this information eﬀectively in
social interactions).
The MSCEIT has been widely used in normal popula-
tions and has been shown to have good face and content
validity [8]. Factor analysis, utilising data from almost 2000
subjects, strongly supports the four-branch model of EI [8].
Higher levels of EI have been shown to be associated with
better social engagement and quality of social interaction
[9]. People with higher levels of EI are less likely to engage
in aggressive behaviour and are less likely to use tobacco or
2 Schizophrenia Research and Treatment
drink excessively [10, 11]. Several studies have demonstrated
small but positive correlations between EI and general
intelligence [7, 12]. These findings suggest that EI is a
useful construct that is reliably associated with real world
functioning in normal subjects.
The National Institute of Mental Health Measure-
ment and Treatment Research to Improve Cognition in
Schizophrenia (MATRICS) initiative evaluated a number of
tests of social cognition and selected the Managing Emotions
branch of the MSCEIT for inclusion in the final MATRICS
Consensus Cognitive Battery (MCCB) [13]. The MCCB,
including the social cognition domain, has since been used
extensively [14]. Whilst the Managing Emotions branch of
the MSCEIT is widely used as part of the MCCB, there have
been only two previous studies utilising the full MSCEIT
battery in people with schizophrenia [15, 16]. Eack et al. [15]
found that the MSCEIT has adequate internal consistency
and reliability in people with schizophrenia. Kee et al. [16]
reported that people with schizophrenia had lower total
MSCEIT scores compared to controls, with significantly
worse performance on the Identifying, Understanding, and
Managing Emotions Branches of the MSCEIT.
Many people with schizophrenia experience diﬃculties
in social functioning, including problems with independent
living, employment, and interpersonal relationships [17].
Whilst negative symptoms and cognitive impairment have
long been known to correlate with social outcomes, these
associations are modest and do not explain all of the
diﬃculties in social functioning evident in schizophrenia
[18]. Recent research has addressed the possibility that
impaired social cognition might also contribute to poor
functional outcome. Bru¨ne et al. [19] administered tests of
general intelligence, executive function, mental state attri-
bution, symptoms, and social behaviour to 38 people with
schizophrenia. Mental state attribution scores accounted for
almost half of the variance in social function. Similarly,
a meta-analysis by Fett et al. [20] showed that social
cognition accounted for 23% of the variance in functional
outcome in schizophrenia. However, there has been less
research specifically investigating the contribution of EI
to social outcome. If EI is found to make a significant
contribution to social function, interventions designed to
remediate deficits in EI may improve outcomes for people
with schizophrenia.
Kee et al. [16] assessed 50 people with schizophrenia
using the MSCEIT. They found modest correlations between
all Branches of the MSCEIT and independent living/self-
care; between Identifying Emotions (Branch 1) and work
productivity, relationships with family and spouse, and psy-
chosocial adjustment and between Understanding Emotions
(Branch 3) and psychosocial adjustment. Eack et al. [15]
reported a significant association between total MSCEIT
scores and the major role functioning subscale of the Social
Adjustment Scale in 64 people with schizophrenia, but
otherwise there was little relationship between MSCEIT
scores and objective measures of functional outcome. A
subgroup of these subjects undertook two years of intensive
therapy designed to improve social cognition, attention,
andmemory. Improvements inManaging Emotions (Branch
4) of the MSCEIT were associated with improvements in
functional outcome [21]. Improved neurocognition, and
in particular improved executive function, was found to
mediate the eﬀects of cognitive enhancement therapy on
functioning.
We developed a pilot study which compared EI, mea-
sured using the MSCEIT Version 2.0, in 20 people with
schizophrenia and 20 controls matched for age, gender, and
years of education. We assessed neurocognition and social
functioning in both groups, and investigated the relation-
ships between EI, neurocognition, and social functioning.
We expected that total EI scores, as well as subscale (Branch)
scores, would be significantly lower in the schizophrenia
group compared to the control group. Specifically, it was
hypothesised that after controlling for neurocognition, a
significant positive correlation would be observed between EI
and social functioning in both the schizophrenia and control
groups. Given that a relationship between the Managing
Emotions Branch (Branch 4) of the MSCEIT and social
function has been demonstrated in previous studies [13, 21]
we hypothesised that this particular branch of the MSCEIT
would bemost strongly associated with social function in our
subjects with schizophrenia.
2. Methods
2.1. Participants. Twenty people meeting the diagnostic
criteria for schizophrenia (DSM-IV-TR) [22] were recruited
from public mental health services across metropolitan
Adelaide, South Australia. The schizophrenia group were
outpatients, living in the community, taking maintenance
antipsychotic medication, and considered clinically stable
by their treating clinicians. Control subjects matched by
age, gender, and years of education were recruited by radio
advertising. Potential control subjects were assessed using
the Mini International Neuropsychiatric Interview (M.I.N.I)
[23] and excluded if any symptoms of psychosis were
present.
All subjects spoke fluent English and were screened for
current major depression, alcohol abuse and dependence,
and substance use disorders by a trained clinician, using the
M.I.N.I [23]. They were excluded if these disorders were
present. Other exclusion criteria for both groups included
intellectual disability or neurological conditions that could
interfere with psychological or cognitive functioning.
All subjects gave written informed consent after the
study had been fully explained. The study was reviewed
and approved by the Central Northern Adelaide Health
Service Ethics of Human Research Committee and the
University of Adelaide, School of Psychology Human Ethics
Subcommittee. This research was carried out in accordance
with the latest version of the Declaration of Helsinki.
2.2. Measures. Participants attended individual testing ses-
sions that lasted for two to three hours. Demographic
data was collected and screening measures administered.
Participants who were eligible to participate in the study
completed the measures of EI, neurocognition, and social
functioning.
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2.2.1. Emotional IntelligenceWasMeasured Using theMSCEIT
V2.0 [8]. The MSCEIT is a self-administered test which
consists of 8 tasks based on 141 items, with two tasks forming
a single branch. Tasks range from identifying emotion in
human faces to identifying strategies to manage emotions in
social situations. The MSCEIT V2.0 provides an overall EI
quotient and four subscale (Branch) scores.
(1) Identifying Emotions (Branch 1) refers to an individ-
ual’s ability to recognise how they and those around
them are feeling [24]. This involves attending to and
decoding emotional signals in other people’s facial
expressions, tone of voice, or posture as well as the
ability to accurately identify emotions within oneself.
(2) Using Emotions (Branch 2) includes an individual’s
knowledge of the link between emotions and think-
ing, and the ability to take feelings into account when
reasoning and problem solving [24, 25].
(3) Understanding Emotions (Branch 3) refers to an
individual’s capacity to analyse emotions, appreciate
their probable trends over time, and to understand
their outcomes [25]. This includes the ability to
recognise groups of related emotional terms and to
understand the antecedents of diﬀerent emotions, for
example, that irritation and frustration might lead to
anger [24].
(4) Managing Emotions (Branch 4) includes the knowl-
edge that it is adaptive to regulate emotions to
facilitate positive social interactions [24, 25].
There are two methods of scoring the MSCEIT V2.0
described in the literature. Responses can be scored accord-
ing to either the general or the expert consensus method,
where scores for each response are weighted according to
either the proportion of a general population sample or
the proportion of a panel of emotion experts that endorsed
the same response [25]. For the current study, the expert
consensus weighted scores were used to ensure that higher
scores represented superior levels of EI [25].
2.2.2. Premorbid Intelligence Was Estimated Using the
National Adult Reading Test (NART). (See [26].)
2.2.3. Current Neurocognitive Functioning Was Assessed Using
the Brief Assessment of Cognition in Schizophrenia (BACS)
[27, 28]. The BACS includes assessments of verbal memory
and learning, working memory, motor function, verbal
fluency, and executive function [27]. BACS scores were
converted to Z scores for statistical analysis [28].
2.2.4. Social Functioning Was Assessed Using the Social Func-
tioning Scale (SFS) [29]. The SFS is a 79-item scale which
measures seven major domains of functioning thought to be
crucial for successful community living for individuals with
schizophrenia.
2.3. Statistical Analysis. Independent-samples t-tests were
used to compare total EI scores, the scores on each Branch
of the MSCEIT V2.0, and total BACS and SFS scores for
the two groups. Pearson’s bivariate correlations were used to
determine the correlation betweenMSCEIT V2.0, BACS, and
SFS scores for each group.
Separate linear regression analyses were performed to
examine the relationship between MSCEIT V2.0 and SFS
scores in each study group, with BACS scores as a potential
mediator variable. To examine the relationships between
variables, the following regression analyses were conducted.
(1) The potential mediator variable (BACS score) was
regressed on the independent variable (MSCEIT V2.0
score);
(2) the dependent variable (SFS score) was regressed on
the independent variable (MSCEIT V2.0 score);
(3) the dependent variable (SFS scores) was regressed on
the potential mediator variable (BACS scores).
To further examine the relationship between EI and
social functioning, multiple regressions were performed for
each group. SFS scores were entered as the dependent
variable in each analysis. To test whether any relationship
between MSCEIT V2.0 and SFS scores was mediated by
BACS scores, BACS scores were entered at Step 1 and total
MSCEIT V2.0 scores were entered at Step 2.
We found that the schizophrenia group had greatest
impairment on the Understanding Emotions Branch of the
MSCEIT V2.0. Exploratory post hoc analyses, using Pear-
son’s bivariate correlations, were undertaken to evaluate the
correlations between scores on the Understanding Emotions
Branch of the MSCEIT V2.0 and total and subscale scores on
the BACS and the SFS. We expected that in the schizophrenia
group, lower Understanding Emotions (Branch 3) MSCEIT
V2.0 scores would be associated with poorer cognitive and
social functioning, with a P value of less than 0.01 accepted
as significant.
There was a significant diﬀerence in premorbid intelli-
gence scores between groups; therefore, a post hoc ANCOVA
was performed to determine diﬀerences in MSCEIT V2.0
scores between groups with NART scores as a covariate.
3. Results
Demographic characteristics are described in Table 1. The
control group scored significantly better than the schizophre-
nia group on the NART.
Diﬀerences between the schizophrenia and the control
group on measures of EI, neurocognition, and social func-
tion are presented in Table 2. The schizophrenia group had
significantly lower scores than controls on all subscales of
the MSCEIT V2.0. The greatest diﬀerence was found on
Understanding Emotions (Branch 3). A post hoc ANCOVA
with calculation of eﬀect size showed that 12% of the
diﬀerence in MSCEIT scores was explained by premorbid
intelligence whilst 24% was explained by group (schizophre-
nia or control).
The schizophrenia group also had significantly lower
scores on all of the BACS subtests. Their scores were lower
than controls on all components of the SFS, and these
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Table 1: Participant demographic and clinical characteristics.
Variable
Schizophrenia Controls
t Cohen’s d P
N Mean (SD) N Mean (SD)
Age 20 43.25 (9.15) 20 38.60 (10.86) 1.47 0.46 0.15
NART score 20 107.45 (6.90) 20 114.00 (4.30) −3.82 1.14 <0.001∗∗∗
Age of illness onset 19 23.63 (7.52)
Duration of illness (years) 19 19.42 (9.90)
Education (years) 20 12.50 (1.99) 20 14.80 (2.50) −3.22 1.02 0.19
N % N % χ2 P
Gender
Male 10 50 10 50
Female 10 50 10 50
Marital status
Married 3 15 9 45
In relationship 3 15 4 20
Single 14 70 7 35 5.48 0.07
∗∗∗Indicates P < 0.001.
Table 2: MSCEIT, BACS, and SFS scores for schizophrenia and control groups.
Schizophrenia mean (SD) Control mean (SD) t 95% CI Cohen’s d P
MSCEIT scores
Branch 1—Perceiving emotions 98.98 (15.57) 110.98 (14.16) −2.55 −21.53, −2.48 0.81 0.02∗
Branch 2—Using emotions 96.14 (14.53) 107.50 (15.79) −2.37 −21.07, −1.64 0.75 0.02∗
Branch 3—Understanding emotions 81.80 (11.63) 105.70 (12.59) −6.23 −31.66, −16.14 1.97 <0.001∗∗∗
Branch 4—Managing emotions 90.75 (12.41) 101.06 (14.74) −2.39 −19.03, −1.59 0.76 0.02∗
MSCEIT global score 86.15 (11.81) 109.45 (14.46) −5.58 −31.76, −14.85 1.77 <0.001∗∗∗
BACS Scores
Verbal memory −2.16 (1.39) −0.20 (1.02) −5.09 −2.75, −1.18 1.92 <0.001∗∗∗
Digit sequencing −0.41 (0.77) 0.54 (0.51) −4.63 −1.37, −0.54 1.86 <0.001∗∗∗
Token motor task −1.21 (1.31) −0.03 (0.68) −3.58 −1.86, −0.51 1.74 0.001∗
Verbal fluency −0.55 (0.97) 0.62 (0.69) −4.41 −1.71, −0.63 1.70 <0.001∗∗∗
Symbol coding −0.88 (0.45) 0.45 (0.59) −7.97 −1.66, −0.99 2.25 <0.001∗∗∗
Tower of london −0.49 (1.04) 0.61 (0.74) −3.82 −1.68, −0.51 1.49 0.001∗
BACS total Z score −1.32 (0.93) 0.52 (0.66) −5.09 −2.36, −1.32 2.28 <0.001∗∗∗
SFS scores
Withdrawal/social engagement 106.18 (11.60) 111.58 (12.41) −1.42 −13.09, 2.29 0.44 0.163
Interpersonal communication 123.95 (19.56) 137.40 (12.40) −2.60 −24.00, −2.90 1.08 0.014∗
Independence performance 107.53 (7.70) 119.80 (7.53) −5.10 −17.15, −7.40 1.63 <0.001∗∗∗
Independence competence 111.85 (7.44) 121.13 (4.02) −4.90 −13.14, −5.40 2.31 <0.001∗∗∗
Recreation 100.39 (26.63) 124.00 (11.66) −3.63 −36.77, −10.45 2.02 0.001∗∗
Prosocial 101.13 (15.38) 114.28 (27.23) −1.88 −27.31, 1.01 0.48 0.068
Employment/occupation 106.43 (15.34) 119.85 (3.79) −3.80 −20.76, −6.09 3.54 0.001∗∗
SFS total score 108.21 (8.03) 121.80 (6.57) −5.86 −18.28, −8.89 1.85 <0.001∗∗∗
∗Indicates P < 0.05, ∗∗indicates P < 0.01, ∗∗∗indicates P < 0.001.
diﬀerences reached significance for five of the seven domains
of social functioning.
The schizophrenia group did not show any significant
correlation between MSCEIT V2.0, BACS, and SFS total
scores (Table 3). The Understanding Emotions Branch of the
MSCEIT V2.0 was significantly correlated with the BACS
Total Z score, SFS independent performance score and the
total SFS score. Managing Emotions (Branch 4) correlated
with the SFS Recreation score. In addition, the BACS Total Z
score correlated with the SFS Interpersonal Communication
score.
In the control group, Using Emotions (Branch 2),
Managing Emotions (Branch 4), and the total MSCEIT
V2.0 score all correlated with the SFS withdrawal/social
engagement subscale. Managing Emotions (Branch 4) also
correlated with the total SFS score.
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Regression analyses for the schizophrenia group revealed
that total MSCEIT V2.0 scores were not a significant
predictor of total BACS scores (b = 0.26, P = 0.28), with
total MSCEIT V2.0 scores accounting for just 6.6% of the
variance in total BACS scores. In addition, neither total
MSCEIT V2.0 scores (b = 0.18, P = 0.45) nor total BACS
scores (b = 0.28, P = 0.23) were significant predictors of
total SFS scores, with each explaining just 7.9% and 3.2% of
the variance in social functioning, respectively.
Together, the total BACS and MSCEIT V2.0 scores
accounted for just 9.1% of the variance in the total SFS
scores. In addition, once total BACS scores were statistically
controlled for, total MSCEIT V2.0 scores accounted for just
1.2% of the variance in the total SFS scores (b = 0.12,
P = 0.64).
Similarly, in the control group, total MSCEIT V2.0 scores
did not significantly predict total BACS scores (b = 0.17,
P = 0.47), with the total MSCEIT V2.0 scores accounting
for just 2.4% of the variance in total BACS scores. Total
MSCEIT V2.0 scores did not predict total SFS scores (b =
0.41, P = 0.07), and similarly total BACS scores did not
predict total SFS scores (b = 0.18, P = 0.45). Hierarchical
analyses for the control group participants showed that the
combined influence of total BACS and total MSCEIT V2.0
scores explained 18.3% of the variance in total SFS scores.
Once total BACS scores were controlled for, total MSCEIT
V2.0 scores accounted for 15.1% of the variance (b = 0.39,
P = 0.10).
Post hoc analysis showed that in the schizophrenia
group, there was a positive correlation between the score for
Understanding Emotions (Branch 3) of the MSCEIT V2.0
and the BACS verbal fluency score (r = 0.646, P = 0.002).
There were no other significant correlations between scores
on Understanding Emotions (Branch 3) of the MSCEIT V2.0
and BACS or SFS subtests scores, for either group.
4. Discussion
Our results replicate the findings of Kee et al. [16] in
demonstrating that people with schizophrenia are impaired
on all aspects of EI, compared to control subjects. Impair-
ment was greatest for Understanding Emotions (Branch
3). Understanding Emotions is assessed using tasks which
require the participant to imagine that a person may be
experiencing a particular emotion, then to imagine that
this emotion may evolve into another related emotion. This
is consistent with the literature showing that people with
schizophrenia have impaired performance on TOM tasks [2],
which assess the ability to correctly infer the thoughts and
feelings of other people.
We had expected that impaired EI would be associated
with poorer cognitive function, and that both EI and neu-
rocognition would predict social outcome. In the schizophre-
nia group, there was a correlation between Understanding
Emotions (Branch 3), the total BACS score, and SFS scores,
confirming that impairment in recognising and understand-
ing the emotions of others, and being able to predict the likely
course of these emotions in a given set of circumstances, is
of particular importance in schizophrenia. The correlation
between Understanding Emotions and the total BACS score
may indicate that the capacity for abstract thought and
prediction of complex emotions and behaviours, necessary
for successful completion of TOM tasks, was lacking in those
with more impaired cognitive function. In turn, lack of
capacity for aﬀective TOM (knowledge about other people’s
emotions) [30] and impaired executive function [31] are
both linked to poor insight, which in turn tends to be
associated with poor outcome [32].
Eack et al. [15] found a positive correlation between all
four Branches of the MSCEIT and a composite neurocog-
nitive score in people with schizophrenia. The composite
neurocognitive score reflected a battery of tests including
processing speed, working memory, verbal memory, and
executive function. Improvements in neurocognition and in
Managing Emotions (Branch 4) were associated with better
functional outcome [31]. Similarly, we found that in the
schizophrenia group that the Managing Emotions Branch
of the MSCEIT correlated with the SFS Recreation score.
Associations between EI and social function were stronger
in the control group, where Using Emotions (Branch 2),
Managing Emotions (Branch 4), and the total MSCEIT score
all correlated with social function.
Fett et al. [20], in a meta-analysis of the associations
between neurocognition, social cognition, and community
functioning in schizophrenia, reported that an overall neu-
rocognitive factor accounted for only 6% of the variance in
community functioning. In the present study, the MSCEIT
did not significantly predict neurocognition or social func-
tioning individually and neurocognition and EI together
accounted for only 9.1% of the variance in social functioning
scores in the schizophrenia group. These findings suggest
that whilst neurocognition and social cognition do make
some contribution to outcome, there are other factors which
have a more substantial impact.
We found that the associations between EI and social out-
comewere stronger in the control group than the schizophre-
nia group. This may reflect the presence of other factors
specific to schizophrenia, such as poor insight or negative
symptoms, modifying social outcome in the control group.
This study was limited by the small sample size, and the
groups were not well matched for premorbid intelligence,
thus the study may have been underpowered. However, our
within group analyses, looking at associations between EI,
neurocognition, and social functioning, were not aﬀected by
this potential confounding factor. The correlational design
of the study means the direction of the relationship between
variables cannot be accurately deduced. For example, in the
control group where a significant correlation between EI
and social functioning was found, it may be the case that
poorer social functioning leads to lower levels of EI, as lack
of social contact results in fewer opportunities for individuals
to learn social norms and gain experience in understanding
the emotional reactions in others.
5. Conclusion
EI has proven to be a very useful construct in the general
population, and further research into EI could contribute
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to our understanding of the nature of deficits in social
cognition in schizophrenia. Our findings provide a basis
for further studies exploring the relationships between
EI, general intelligence, the various domains of cognitive
function, and functional outcome in schizophrenia. A deeper
understanding of the scope and clinical correlations of
social cognitive deficits may help to identify targets of new
treatments to improve emotional processing and functional
outcome.
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